Unless otherwise indicated or otherwise indicated, references to the effectiveness of this offer and the use of revenues derived therefrom presuppose the complete physical liquidation of the futures sale agreement and an initial futures selling price of $46.19 per share, the last reported sale price of our common shares on November 15, 2019 and not the exercise of the underwriter option to purchase additional shares. A total of 922,357 shares are eligible in the event of the exercise of options, 29,944 shares are eligible under one of the restricted stocks and 1,505,433 shares are reserved for future issuance under the 2015 Omnibus Incentive plan. These shares are admitted for sale on the public market as soon as these shares are issued, subject to various exercise agreements, foreclosure agreements and Rule 144. In addition, 1,106,866 shares of Restricted Stock are outstanding. Foodservice`s EBITDA increased 50.2% in the first quarter compared to the same period last year to $156.2 million. Gross yield increased by 33.1% in the first quarter of fiscal 2021 due to the acquisition of Reinhart compared to the same period last year. The increase was partially offset by the decrease in the number of cases and net sales discussed above. In the first three months of fiscal 2021, Foodservice recorded $8.1 million in reserves, mainly due to the impact of COVID-19, an increase of $2.8 million over the previous year. In the first three months of fiscal 2021, the acquisition of Reinhart resulted in an increase of 28.6% compared to the same period of the previous year.

In the first quarter of fiscal 2021, Foodservice recorded a reserve benefit of $US 6.2 million for expected credit losses compared to credit losses of $2.8 million for the first quarter of fiscal 2020. The increase in operating expenses was also partially offset by a decrease in personnel and fuel costs compared to the same period of the previous year. The sub-authors have been granted an option of 30 days from the date of this prospectus supplement, which may be exercised in whole or in part from time to time to acquire up to 1,380,000 additional ordinary shares at the IPO price less subscription discounts and commissions. In exercising this option, the number of shares of our common shares underlying the futures contract will be increased by the number of shares sold by the term buyer or his related company in connection with the exercise of such an option. In this case, if the forward buyer or his related company does not supply and sell all the shares of our common shares that he is supposed to sell in connection with the exercise of this option, we will issue and sell to the conassureurs a number corresponding to the number of shares that the forward buyer or his partner does not provide or sell. and the number of shares underlying the sale agreement in the future will not increase with respect to the number of shares we issue and sell. The decision of the forward buyer to exercise his right to accelerate the settlement of the forward sales contract is taken independently of our interests, including our capital needs. . . .